Skip to main content
. 2019 Mar 16;14(4):392–404. doi: 10.1080/15592294.2019.1588684

Figure 7.

Figure 7.

ALOX5AP and CSF3R were associated with oncogenesis and prognosis of CRC. (a) ALOX5AP had decreased promoter DNA methylation (N = 125 tumors and N = 29 normal tissues;unpaired t-test, P < 0.05, *; P < 0.01, **; P < 0.001, ***) and elevated expression (N = 26 tumors and N = 26 normal tissues;unpaired t-test) in CRC. When compared in DNMTs groups, ALOX5AP showed significantly downregulated methylation and upregulated expression in samples with DNMT mutation (N = 28 mutations and N = 186 non-mutations;unpaired t-test). (b) CSF3R showed decreased promoter DNA methylation and elevated expression in CRC. When compared in DNMTs groups, CSF3R had significantly downregulated methylation patterns and upregulated expressions in samples with DNMTs mutation. (c) Pearson correlations of ALOX5AP expression with the abundance of infiltrating neutrophils. (d) Pearson correlations of CSF3R expression with the abundance of infiltrating neutrophils. (e) Kaplan-Meier survival plot of two tumour groups classified by the mRNA expression of ALOX5AP. F. Kaplan-Meier survival plot of two tumour groups classified by the mRNA expression of CSF3R.